Kashyap Tele-Medicines Ltd
Incorporated in 1976, Kashyap Tele-Medicines Ltd is engaged in software sales and its maintenance and services.[1]
- Market Cap ₹ 28.1 Cr.
- Current Price ₹ 5.89
- High / Low ₹ 12.5 / 2.68
- Stock P/E
- Book Value ₹ 0.12
- Dividend Yield 0.00 %
- ROCE 0.00 %
- ROE 0.00 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Stock is trading at 51.1 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -1.02% over past five years.
- Company has a low return on equity of -1.53% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Information Technology Information Technology IT - Services IT Enabled Services
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.12 | 0.12 | 0.13 | 0.15 | 0.18 | 0.20 | 0.20 | 0.19 | 0.20 | 0.20 | 0.19 | 0.19 | 0.04 | |
| 0.09 | 0.09 | 0.10 | 0.10 | 0.13 | 0.17 | 0.19 | 0.18 | 0.31 | 0.20 | 0.22 | 0.19 | 0.23 | |
| Operating Profit | 0.03 | 0.03 | 0.03 | 0.05 | 0.05 | 0.03 | 0.01 | 0.01 | -0.11 | 0.00 | -0.03 | 0.00 | -0.19 |
| OPM % | 25.00% | 25.00% | 23.08% | 33.33% | 27.78% | 15.00% | 5.00% | 5.26% | -55.00% | 0.00% | -15.79% | 0.00% | -475.00% |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.62 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.03 | 0.03 | 0.03 | 0.05 | 0.05 | 0.03 | 0.01 | 0.01 | -1.73 | 0.00 | -0.03 | 0.00 | -0.19 |
| Tax % | 0.00% | 0.00% | 33.33% | 20.00% | 20.00% | 33.33% | 0.00% | 0.00% | 0.00% | 0.00% | |||
| 0.02 | 0.03 | 0.02 | 0.04 | 0.04 | 0.02 | 0.01 | 0.01 | -1.73 | 0.00 | -0.03 | 0.00 | -0.19 | |
| EPS in Rs | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | -0.36 | 0.00 | -0.01 | 0.00 | -0.04 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -1% |
| 3 Years: | -2% |
| TTM: | -80% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -533% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 43% |
| 1 Year: | 109% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -2% |
| 3 Years: | -2% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.89 | 4.89 | 4.89 | 4.89 | 4.77 | 4.77 | 4.77 | 4.77 | 4.77 | 4.77 | 4.77 | 4.77 | 4.77 |
| Reserves | -2.66 | -2.64 | -2.62 | -2.59 | -2.43 | -2.40 | -2.39 | -2.38 | -4.11 | -4.10 | -4.13 | -4.13 | -4.22 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 | 0.01 | 0.01 | 0.02 | 0.01 | 0.05 | 0.02 | 0.09 | |
| Total Liabilities | 2.24 | 2.26 | 2.29 | 2.33 | 2.37 | 2.41 | 2.39 | 2.40 | 0.68 | 0.68 | 0.69 | 0.66 | 0.64 |
| 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2.02 | 2.05 | 2.08 | 2.12 | 2.16 | 2.20 | 2.18 | 2.19 | 0.68 | 0.68 | 0.69 | 0.66 | 0.64 | |
| Total Assets | 2.24 | 2.26 | 2.29 | 2.33 | 2.37 | 2.41 | 2.39 | 2.40 | 0.68 | 0.68 | 0.69 | 0.66 | 0.64 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.06 | 0.04 | 0.04 | -0.08 | 0.05 | 0.03 | -0.04 | 0.03 | -0.11 | 0.07 | 0.00 | -0.09 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | -0.06 | 0.04 | 0.04 | -0.08 | 0.05 | 0.03 | -0.04 | 0.03 | -0.11 | 0.07 | 0.00 | -0.09 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 425.83 | 395.42 | 365.00 | 292.00 | 243.33 | 219.00 | 237.25 | 268.95 | 0.00 | 0.00 | 19.21 | 0.00 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 425.83 | 395.42 | 365.00 | 292.00 | 243.33 | 219.00 | 237.25 | 268.95 | 0.00 | 0.00 | 19.21 | 0.00 |
| Working Capital Days | 456.25 | 365.00 | 308.85 | 267.67 | 223.06 | 164.25 | 273.75 | 288.16 | 0.00 | 0.00 | -76.84 | -19.21 |
| ROCE % | 1.35% | 1.34% | 1.33% | 2.19% | 2.16% | 1.27% | 0.42% | 0.42% | -7.21% | 0.00% | -4.58% | 0.00% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - Publication of Standalone Un-Audited Financial Results for Third Quarter and Nine Months ended on December 31, 2025 in Newspaper.
- Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31, 2025, Along With The Statutory Auditors' Limited Review Report 10 Feb
-
Board Meeting Outcome for Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31, 2025, Along With The Statutory Auditors' Limited Review Report
10 Feb - Approved unaudited Q3 and nine-month results for period ended Dec 31, 2025.
-
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (LODR) Regulations, 2015
21 Jan - Board meeting on 10 Feb 2026 to approve Q3 results ended 31 Dec 2025.
-
Announcement under Regulation 30 (LODR)-Resignation of Director
7 Jan - Three independent directors resigned w.e.f. 14 Aug 2025 after acquirers' open offer, citing pre-occupancy.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
KTML offers Information Technology related services and software sales. It is planning to diversify the existing business activities into
the packaging of medical instruments segments under the flagship of its new management.